Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
8.71-0.43 (-4.70%)
At close: 4:00PM EDT
8.69 -0.02 (-0.23%)
After hours: 07:57PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.14
Open9.25
Bid8.71 x 1400
Ask9.00 x 1000
Day's Range8.68 - 9.30
52 Week Range2.93 - 13.10
Volume363,508
Avg. Volume5,430,318
Market Cap139.923M
Beta (5Y Monthly)2.00
PE Ratio (TTM)N/A
EPS (TTM)-2.29
Earnings DateNov 10, 2021 - Nov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.00
  • TipRanks

    2 Cutting-Edge Biotech Stocks That Can Double in Value (Or More)

    For more risk-tolerant investors, biotechs are screaming buys. This space is consistently on the Street’s radar as a single catalyst such as a positive FDA outcome or promising trial results can send shares through the roof. For example, last week ChemoCentryx (CCXI) saw its share prices skyrocket 100% in just one day, after the FDA approved its blood vessel inflammation drug Tavneos. However, the reverse also holds true meaning that biotech stocks carry their fair share of risk. So how are inve

  • Zacks

    Do Options Traders Know Something About aTyr Pharma (LIFE) Stock We Don't?

    Investors need to pay close attention to aTyr Pharma (LIFE) stock based on the movements in the options market lately.

  • GlobeNewswire

    aTyr Pharma to Participate in Piper Sandler Investor Lung Day

    SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer, will participate in a fireside chat as part of the Piper Sandler Virtual Investor Day: Developing Therapeutics for Lung Indications on Friday, October 15, 2021, at 9:00am ET / 6:00am PT. The discussion wi

Advertisement
Advertisement